CATALYST PHARMACEUTICALS, INC. - Director's Dealing 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2024-08-21

Reporting Person: Tierney David S (Director)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-08-21	Common stock, par value $0.001 per share	M	15000	$4.01	Acquired	363874	Direct
2024-08-21	Common stock, par value $0.001 per share	S	15000	$20.097	Disposed	348874	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-08-22	Options to purchase common stock	$4.01	M	15000	Acquired	2025-01-02	Common Stock (15000)	Direct

F1: Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.

F2: Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $20.00 to $20.485 per share.

F3: Options vested in three annual tranches beginning on January 2, 2019.